Connect Biopharma Holdings Ltd. (CNTB)
NASDAQ · Healthcare
Connect Biopharma Holdings Ltd. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 64,000 | 26.0M | 0 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -58.1M | -22.5M | -69.1M |
| EBITDA | -57.4M | -21.8M | -68.3M |
| Net Income | -55.5M | -15.6M | -62.1M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 56M | 55M | 55M |
Connect Biopharma Holdings Ltd. Income Statement — FAQ
Connect Biopharma Holdings Ltd. (CNTB) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CNTB's income statement history?
The chart and table above show Connect Biopharma Holdings Ltd.'s income statement by year and by quarter, including the growth rate.